Brown Advisory Inc Gilead Sciences, Inc. Transaction History

Brown Advisory Inc

  • $77.3 Billion
  • Q3 2024

A detailed history of Brown Advisory Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Brown Advisory Inc holds 291,051 shares of GILD stock, worth $27.1 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
291,051
Previous 259,422 12.19%
Holding current value
$27.1 Million
Previous $17.8 Million 37.07%
% of portfolio
0.03%
Previous 0.02%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$66.59 - $83.99 $2.11 Million - $2.66 Million
31,629 Added 12.19%
291,051 $24.4 Million
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $396,708 - $457,832
6,282 Added 2.48%
259,422 $17.8 Million
Q1 2024

Apr 24, 2024
BUY
$71.58 - $87.29 $2.12 Million - $2.58 Million
29,588 Added 13.24%
253,140 $18.5 Million
Q4 2023

Feb 08, 2024
SELL
$73.27 - $83.09 $1.53 Million - $1.73 Million
-20,825 Reduced 8.52%
223,552 $18.1 Million
Q3 2023

Oct 24, 2023
SELL
$73.94 - $80.67 $238,086 - $259,757
-3,220 Reduced 1.3%
244,377 $18.3 Million
Q2 2023

Jul 31, 2023
SELL
$76.01 - $86.7 $628,982 - $717,442
-8,275 Reduced 3.23%
247,597 $19.1 Million
Q1 2023

May 08, 2023
BUY
$77.31 - $88.08 $1.18 Million - $1.35 Million
15,324 Added 6.37%
255,872 $21.2 Million
Q4 2022

Feb 13, 2023
SELL
$62.32 - $89.47 $37,578 - $53,950
-603 Reduced 0.25%
240,548 $20.7 Million
Q3 2022

Nov 14, 2022
BUY
$59.54 - $68.01 $2.4 Million - $2.74 Million
40,299 Added 20.06%
241,151 $14.9 Million
Q2 2022

Nov 14, 2022
BUY
$57.72 - $65.01 $225,165 - $253,604
3,901 Added 1.98%
200,852 $12.4 Million
Q2 2022

Sep 13, 2022
BUY
$57.72 - $65.01 $406,926 - $458,320
7,050 Added 3.48%
209,875 $13 Million
Q2 2022

Aug 02, 2022
BUY
$57.72 - $65.01 $95,526 - $107,591
1,655 Added 0.82%
202,825 $13 Million
Q1 2022

Nov 14, 2022
SELL
$57.92 - $72.58 $748,558 - $938,023
-12,924 Reduced 6.16%
196,951 $11.7 Million
Q1 2022

Sep 13, 2022
BUY
$57.92 - $72.58 $128,234 - $160,692
2,214 Added 1.11%
201,170 $12 Million
Q1 2022

May 09, 2022
BUY
$57.92 - $72.58 $961,356 - $1.2 Million
16,598 Added 9.1%
198,956 $12.5 Million
Q4 2021

Jan 27, 2022
BUY
$64.88 - $73.64 $344,383 - $390,881
5,308 Added 3.0%
182,358 $13.2 Million
Q3 2021

Nov 12, 2021
BUY
$67.69 - $73.03 $1.79 Million - $1.93 Million
26,484 Added 17.59%
177,050 $12.4 Million
Q2 2021

Jul 29, 2021
BUY
$63.47 - $69.35 $132,017 - $144,248
2,080 Added 1.4%
150,566 $10.4 Million
Q1 2021

May 14, 2021
SELL
$60.0 - $68.46 $24,780 - $28,273
-413 Reduced 0.28%
148,486 $9.6 Million
Q4 2020

Feb 12, 2021
SELL
$56.65 - $64.55 $1.42 Million - $1.61 Million
-25,007 Reduced 14.38%
148,899 $8.68 Million
Q3 2020

Nov 16, 2020
SELL
$62.1 - $78.08 $961,991 - $1.21 Million
-15,491 Reduced 8.18%
173,906 $11 Million
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $246,028 - $285,684
3,401 Added 1.83%
189,397 $14.6 Million
Q1 2020

May 15, 2020
BUY
$62.63 - $80.22 $2.93 Million - $3.76 Million
46,841 Added 33.66%
185,996 $13.9 Million
Q4 2019

Feb 14, 2020
BUY
$61.62 - $67.78 $1.47 Million - $1.61 Million
23,800 Added 20.63%
139,155 $9.04 Million
Q3 2019

Nov 14, 2019
BUY
$62.51 - $69.0 $756,308 - $834,831
12,099 Added 11.72%
115,355 $7.31 Million
Q2 2019

Aug 12, 2019
SELL
$61.87 - $69.38 $1.18 Million - $1.32 Million
-19,065 Reduced 15.59%
103,256 $6.98 Million
Q1 2019

May 15, 2019
BUY
$62.53 - $70.05 $1.4 Million - $1.57 Million
22,348 Added 22.35%
122,321 $7.95 Million
Q4 2018

Feb 13, 2019
BUY
$60.54 - $79.0 $2.71 Million - $3.54 Million
44,785 Added 81.15%
99,973 $6.25 Million
Q3 2018

Nov 13, 2018
SELL
$71.28 - $78.92 $371,511 - $411,331
-5,212 Reduced 8.63%
55,188 $4.26 Million
Q2 2018

Aug 10, 2018
BUY
$64.88 - $75.68 $13,170 - $15,363
203 Added 0.34%
60,400 $4.28 Million
Q1 2018

Jun 28, 2018
BUY
$72.84 - $88.8 $1.47 Million - $1.79 Million
20,188 Added 50.46%
60,197 $4.54 Million
Q1 2018

May 14, 2018
SELL
$72.84 - $88.8 $887,336 - $1.08 Million
-12,182 Reduced 23.34%
40,009 $3.02 Million
Q4 2017

Feb 12, 2018
SELL
$71.15 - $83.52 $104,519 - $122,690
-1,469 Reduced 2.74%
52,191 $3.74 Million
Q3 2017

Nov 13, 2017
SELL
$72.11 - $85.47 $294,208 - $348,717
-4,080 Reduced 7.07%
53,660 $4.35 Million
Q2 2017

Aug 14, 2017
BUY
N/A
57,740
57,740 $4.09 Million

Others Institutions Holding GILD

# of Institutions
1,942
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $117B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email